Infermedica is a Poland-founded digital health company that offers a B2B AI-powered Medical Guidance Platform for symptom analysis, preliminary diagnosis and patient triage. Its platform automates patient triage, intake and post-visit follow-up for health systems, payers and providers and includes a symptom checker, an AI tool to support call operators and an API for custom diagnostic solutions. The product is used in more than 30 countries, available in 19 languages, and has completed over 10 million health checks. The company intends to develop new modules to cover the full primary care journey and to expand its underlying AI disease coverage and accuracy. Commercially, Infermedica plans to strengthen its position in the U.S. and DACH and will focus the majority of its sales and marketing efforts there. The team grew 80% to 180 specialists last year and the company expects to nearly double headcount in the next 12 months. Infermedica provides an AI-driven, API-first platform for symptom checking, preliminary diagnosis and patient triage, sold primarily to insurers, telemedicine providers and health systems on a B2B basis. The product is white-labeled for customers and integrates with chatbots, patient portals and EHRs; Microsoft has integrated the platform into its health bot. The company reports nearly 40,000 hours of physician work contributed and 6,000,000 completed user checkups across its platform. Infermedica licenses its technology on a SaaS basis, charging by API calls or completed patient checkups. Management says new funds will be used for platform R&D to enhance triage, symptom-checking and clinical decision support. The company plans to expand operations in Germany and the U.S. Infermedica builds an AI-driven symptom checker that asks users follow-up questions and helps guide patients to appropriate care options such as virtual follow-up, urgent care, or the emergency room. The company trains its algorithm using curated medical literature and external datasets, supported by a medical team of about 20 people and over 20,000 hours of literature curation. In addition to the symptom checker, Infermedica offers call-center triage services and a medical API as white-label solutions for insurers, hospital systems, and health IT companies. Founded in Poland in 2012, the startup pivoted from a direct-to-consumer model to a B2B model to improve monetization. It plans to implement a closed-loop system to continuously learn from anonymized patient interactions and physician diagnoses. The company has recently expanded into the United States and is hiring US roles, including head of sales and head of marketing. Financially, Infermedica disclosed a new $3.65 million funding round to support product development and its US expansion.

Total raised

$44M

Funding rounds

3

Latest round

Series B

Latest activity

Jan 2022